首页 工具
登录
购物车

搜索结果

Search Results for " 曲妥珠单抗 "
Targets Recommended: EGFR ADC Antibody

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T9912 Trastuzumab

EGFR; ADC Antibody Angiogenesis; Antibody-drug Conjugate/ADC Related; JAK/STAT signaling; Tyrosine Kinase/Adaptors
Trastuzumab 属于人源化单克隆抗体,可以高亲和力与 HER2 选择性结合。Trastuzumab 具有抗肿瘤活性,可用于治疗 HER2 阳性肿瘤。Trastuzumab 可以诱导细胞周期阻滞,介导细胞毒性,抑制 DNA 损伤修复。
T36646 Trastuzumab deruxtecan

DS-8201a,VRN-101099,DS 8201,T-DXd

Others; Antibody-Drug Conjugates (ADCs) Antibody-drug Conjugate/ADC Related; Others
Trastuzumab deruxtecan (T-DXd) 是一种具有抗癌抗肿瘤活性的抗体-活性分子偶联物 (ADC)。Trastuzumab deruxtecan 对 HER2 阳性乳腺癌和胃癌有改善作用。
T77440 Codrituzumab

RG-7686,RO5137382,GC33

Codrituzumab (GC3)是一种人源化针对 glypican-3 肝癌蛋白的抗体,可与索拉非尼联合使用来研究不可治愈的晚期肝细胞癌 (HCC) 。
T36647 Trastuzumab emtansine

Others; Antibody-Drug Conjugates (ADCs) Antibody-drug Conjugate/ADC Related; Others
Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that combines the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of DM1, a microtubule-inhibitory derivative of maytansine. This compound is utilized in the investigation of advanced breast cancer[1][2].
T9996 NCT-58

NCT58

HSP Cytoskeletal Signaling; Metabolism
NCT-58是一种有效的C 端HSP90抑制剂。NCT-58不会引起热休克反应(HSR)。NCT-58通过同时下调HER 家族成员以及抑制Akt 磷酸化来激发抗肿瘤活性。NCT-58杀死对曲妥珠单抗耐药的乳腺癌干细胞样细胞。NCT-58诱导HER2阳性乳腺癌细胞凋亡。

化合物

Trastuzumab
Cat.No: T9912
Synonym:
Target: EGFR, ADC Antibody
Trastuzumab deruxtecan
Cat.No: T36646
Synonym: DS-8201a,VRN-101099,DS 8201,T-DXd
Target: Others, Antibody-Drug Conjugates (ADCs)
Codrituzumab
Cat.No: T77440
Synonym: RG-7686,RO5137382,GC33
Target:
Trastuzumab emtansine
Cat.No: T36647
Synonym:
Target: Others, Antibody-Drug Conjugates (ADCs)
NCT-58
Cat.No: T9996
Synonym: NCT58
Target: HSP
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼